CorVel Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für CorVel zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum20.8%
Wachstumsrate der Einnahmenn/a
Zukünftige Eigenkapitalrenditen/a
Analystenabdeckung

None

Zuletzt aktualisiertn/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Oct 22
Subdued Growth No Barrier To CorVel Corporation's (NASDAQ:CRVL) Price

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Aug 27
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

Jul 30
Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

Jul 12
CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 25
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Apr 07
CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Mar 19
Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Jan 10
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

Dec 23
The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Dec 05
With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Oct 10
CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Sep 01
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

Jul 10
We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 11
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Mar 24
If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Jan 06
A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Dec 19
Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

Sep 21
CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25
We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21
CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14
With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da CorVel jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:CRVL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
9/30/20248468273107N/A
6/30/20248177871103N/A
3/31/2024795767099N/A
12/31/2023774757097N/A
9/30/2023751757297N/A
6/30/2023733696689N/A
3/31/2023719665682N/A
12/31/2022704685686N/A
9/30/2022690654072N/A
6/30/2022670665183N/A
3/31/2022646663767N/A
12/31/2021620624971N/A
9/30/2021597596890N/A
6/30/2021576557393N/A
3/31/2021553467794N/A
12/31/2020554437088N/A
9/30/2020561415274N/A
6/30/2020572424270N/A
3/31/2020592474881N/A
12/31/2019596474477N/A
9/30/2019594485076N/A
6/30/2019595486282N/A
3/31/2019596476379N/A
12/31/2018588445980N/A
9/30/2018583435780N/A
6/30/201857139N/A64N/A
3/31/201855836N/A62N/A
12/31/201754835N/A65N/A
9/30/201753632N/A62N/A
6/30/201752831N/A65N/A
3/31/201751929N/A52N/A
12/31/201651328N/A51N/A
9/30/201650928N/A47N/A
6/30/201650529N/A44N/A
3/31/201650429N/A51N/A
12/31/201549727N/A48N/A
9/30/201549628N/A53N/A
6/30/201549527N/A50N/A
3/31/201549329N/A44N/A
12/31/201449131N/A42N/A
9/30/201448933N/A42N/A
6/30/201448534N/A48N/A
3/31/201447934N/A55N/A
12/31/201347134N/A57N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CRVL über der Sparquote liegt (2.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CRVL schneller wachsen werden als der Markt US

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CRVL in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CRVL schneller wachsen werden als der Markt von US.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CRVL schneller wachsen werden als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CRVL in 3 Jahren voraussichtlich hoch sein wird


Wachstumsunternehmen entdecken